Synonyms:
Status: Phase 3
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: 10T6626FRK

Structure

InChI Key YKPYIPVDTNNYCN-INIZCTEOSA-N
Smile CC1(C)SCCN(S(=O)(=O)c2ccc(Oc3ccncc3)cc2)[C@H]1C(=O)NO
InChI
InChI=1S/C18H21N3O5S2/c1-18(2)16(17(22)20-23)21(11-12-27-18)28(24,25)15-5-3-13(4-6-15)26-14-7-9-19-10-8-14/h3-10,16,23H,11-12H2,1-2H3,(H,20,22)/t16-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C18H21N3O5S2
Molecular Weight 423.52
AlogP 2.26
Hydrogen Bond Acceptor 7.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 5.0
Polar Surface Area 108.83
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 28.0

Pharmacology

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Prostatic Neoplasms, Castration-Resistant 3 D064129 ClinicalTrials
Lung Neoplasms 3 D008175 ClinicalTrials
Central Nervous System Neoplasms 2 D016543 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 192329-42-3
ChEBI 138885
ChEMBL CHEMBL75094
DrugBank DB05100
EPA CompTox DTXSID3043946
FDA SRS 10T6626FRK
Guide to Pharmacology 6505
PDB PN0
PubChem 466151
SureChEMBL SCHEMBL115696
ZINC ZINC000000580328